Position history for GLENVIEW CAPITAL MANAGEMENT, LLC's holdings in MYRIAD GENETICS INC
GLENVIEW CAPITAL MANAGEMENT, LLC holds 5.4M shares of MYGN (MYRIAD GENETICS INC), worth $24.4M as of 2026-Q1. The position was increased (+18.0% shares). MYGN represents 0.6% of GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio.
Current Value
$24.4M
Current Shares
5.4M
Total Value Change
-$67.3M
Total Shares Change
+1.7M
Other major holders of MYGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 5.4M |
+18.0% |
| $24.4M |
| 0.6% |
| $5.29 |
48 |
| 2025-Q4 | Unchanged | 4.6M | 0.0% | $28.2M | 0.6% | $6.17 | 0 |
| 2025-Q3 | Unchanged | 4.6M | 0.0% | $33.2M | 0.7% | $7.24 | 0 |
| 2025-Q2 | Increased | 4.6M | +17.6% | $24.4M | 0.7% | $5.25 | 48 |
| 2025-Q1 | Decreased | 3.9M | -6.2% | $34.6M | 0.9% | $8.88 | 0 |
| 2024-Q4 | Increased | 4.2M | +229.6% | $57M | 1.4% | $13.63 | 76 |
| 2024-Q3 | Decreased | 1.3M | -66.3% | $34.6M | 0.7% | $26.46 | 0 |
| 2024-Q2 | Decreased | 3.7M | -24.2% | $91.7M | 1.8% | $24.46 | 0 |